Trial Profile
Study of apoptosis-associated molecules erythroid differentiation regulator 1, bcl-2 and p53 in actinic keratosis after treatment with ingenol mebutate
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2018
Price :
$35
*
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Pharmacodynamics
- 10 Aug 2018 New trial record